| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | 0.0055 | 0.9 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | -0.0037 | 0.9 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | -0.0047 | 0.9 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | 0.0047 | 0.9 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.0037 | 0.9 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.0034 | 0.9 |
| mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | -0.0045 | 0.9 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.0035 | 0.9 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | 0.0042 | 0.9 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.0052 | 0.9 |